Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
about
Tracking antigen-specific T-cells during clinical tolerance induction in humansImmunological mechanisms of allergen-specific immunotherapyAllergen-specific immunotherapy: is it vaccination against toxins after all?Immunotherapy in food allergy.Mechanisms of allergen-specific immunotherapy.Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).Allergen immunotherapy: current and new therapeutic strategies.Mechanisms of interleukin-10-mediated immune suppression.Recombinant house dust mite allergens.Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.Inhibition of human T-cell responses by allergen peptides.Regulatory T cells in many flavors control asthmaRecombinant Hymenoptera venom allergens.Systemic reactions to allergen immunotherapy: a review of the literature.Mechanisms of immune tolerance to allergens: role of IL-10 and TregsPeptide immunotherapy for allergic disease.Specific immunotherapy in atopic dermatitis.Tregs and allergic diseaseIL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.Advances in allergen-specific immunotherapy.Targets in allergy-directed immunotherapy.Immune modulating peptides for the treatment and suppression of multiple sclerosis.T regulatory cells in allergen-specific immunotherapy.T regulatory cells and the control of allergic disease.Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals.It is time to beelieve the CD1a hype!Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice.CD70-CD27 ligation between neural stem cells and CD4+ T cells induces Fas-FasL-mediated T-cell death.Allergy vaccines: dreams and reality.The effect of rush immunotherapy with house dust mite in the production of IL-5 and IFN-gamma from the peripheral blood T cells of asthmatic children.Role of interleukin 10 in specific immunotherapy.Mechanisms of immune tolerance to allergens in childrenAntigen-specific immunotherapy of autoimmune and allergic diseasesHymenoptera venom immunotherapy.Immunological mechanisms of allergen-specific immunotherapy.Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.Mechanisms of immunotherapy to wasp and bee venom.Regulatory cells in allergen-specific immunotherapy.Honeybee venom immunotherapy: certainties and pitfalls.
P2860
Q24320083-224052A0-2A70-4885-BAD1-2EAA7A9E6FD0Q28265326-552E58C6-0E16-48E5-A99D-D6BA01BF4C7BQ30248317-1C234F9C-6B49-4E7B-821E-DFD949077FCBQ33899364-0F46530B-B37B-4370-AC2E-6A1CCF6D826DQ33945896-24310F2E-B46B-4197-A21D-B23FD4E1C72FQ33999649-944344AC-E371-4824-95DE-6AA6EC49EFD3Q34074753-35B098D3-B530-41DB-A406-D307B51FC2BCQ34285968-0FD712CA-1522-44C5-A3C0-17C761E2DA5AQ34361546-72C75CBC-4BE6-4627-94C5-EFDAC8371D53Q34548321-40605445-0219-4DB7-91FF-AE87E3EDBF0CQ34567734-941EB145-CE19-4B83-8665-54EA0B61B864Q34574231-B1950499-F30B-4379-BFD1-34FEC23E700CQ34722774-D3EB011E-FCE7-4389-A18F-F104D047A757Q35098554-C12DCE2B-84FF-4D53-BDE6-19CE7A3282C6Q35140130-F21AA83E-9A83-40DD-883F-539B67ED490BQ35164800-9AEB28F9-78E2-4A25-9AB3-C7C8E6E042D5Q35420502-872587CF-59B7-48DC-B4F6-5F5357324C7CQ35951537-FE9AD071-BD69-437E-9723-1F3A49AA354AQ36009860-F434BC87-0F24-4E17-95DF-CD960EB6C4C5Q36150445-8260C93E-5BF2-4C89-9C95-37375A155DD3Q36150810-8A63B618-915B-446F-B429-B4E177F5973DQ36151968-1DB2064F-FF58-4345-A779-BBBC9CA18A65Q36327399-A775BB84-9605-4E4D-B4C8-819479450EBCQ36377204-B6E5E686-6ACA-449A-B45E-390E7AF2978AQ36429815-A495C9FE-6CCD-4FFC-A0CA-6FF6A6AAD808Q36536816-4AAE13CE-81F9-4209-84E4-8F7EDC5AF902Q36592678-D8884913-20CA-4342-8D59-41FD852A96CCQ36946923-F45952FD-EAAF-4D25-BA84-77290A473B08Q36998531-F6513664-2F13-4FCB-8FED-08F9154C4A77Q37123463-DE41A608-B92E-4AA4-AB4B-7808B1B0D32DQ37232011-D3BA1D0B-5202-4EEE-BE1B-A903CF5FED4DQ37387064-73F2305B-BE58-4A40-8BAF-A1CEBC079A5DQ37453510-23A6BC60-C9C0-4C8D-B27F-E8AEA629037EQ37790023-D8F270A3-AB07-4A08-AD2B-4B77C597CFC6Q37842330-B17950EC-C73E-43B2-AC1D-BDA9EC160D1BQ37861875-F7713099-53A0-4A11-B621-D5E6F0C2ECDEQ37888684-A0CDD7E0-6E09-4F6B-9286-27F9C0FA11DFQ37897667-4B0B8933-CC09-4198-9148-061ECC603A07Q38003474-51DA060D-C679-4F8D-8123-6697FC07821FQ38063584-80E7D772-ABE4-417D-9ECE-06F582D731CA
P2860
Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epitope-specific T cell tolera ...... ry by IL-2 and IL-15 in vitro.
@en
Epitope-specific T cell tolera ...... ry by IL-2 and IL-15 in vitro.
@nl
type
label
Epitope-specific T cell tolera ...... ry by IL-2 and IL-15 in vitro.
@en
Epitope-specific T cell tolera ...... ry by IL-2 and IL-15 in vitro.
@nl
prefLabel
Epitope-specific T cell tolera ...... ry by IL-2 and IL-15 in vitro.
@en
Epitope-specific T cell tolera ...... ry by IL-2 and IL-15 in vitro.
@nl
P2093
P2860
P356
P1476
Epitope-specific T cell tolera ...... ry by IL-2 and IL-15 in vitro.
@en
P2093
P2860
P304
P356
10.1172/JCI118963
P407
P577
1996-10-01T00:00:00Z